THREE Small Molecule Drug Discovery Platforms

Elegance in Molecular Design to Target, Bind and Kill Cancer

  • Anti-Angiogenic / Tubulin Inhibitor

    Multi-acting single agent for highly vascularized tumors, including:

    • Glioblastoma Multiforme (GBM)

    • Diffuse Intrinsic Pontine Glioma (DIPG)

  • Folate Receptor-⍺ / GARFTase Inhibitor

    Multi-acting single agent for tumors that over express FR-α , including:

    • Ovarian Cancer

    • Mesothelioma

  • Folate Receptor-⍺ / SHMT-2 Inhibitor

    Multi-acting single agent for tumors that over express FR-α, including:

    • Pancreatic Cancer